NCT04587869

Brief Summary

This study consists of a randomized controlled trial of a multi-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM). Primary intervention objectives include increasing health care engagement and receipt of evidence-based preventive care, as well as better coping and reduced anticipated and internalized stigma, and medical mistrust among intervention participants.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
369

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 14, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

February 9, 2021

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2025

Completed
8 months until next milestone

Results Posted

Study results publicly available

November 13, 2025

Completed
Last Updated

November 13, 2025

Status Verified

October 1, 2025

Enrollment Period

4.1 years

First QC Date

October 1, 2020

Results QC Date

October 7, 2025

Last Update Submit

October 31, 2025

Conditions

Keywords

Black/African American sexual minority men

Outcome Measures

Primary Outcomes (2)

  • Inadequate Healthcare Utilization

    Indicator that the individual reported (1) fewer than 1 ambulatory visit AND (2) at least 1 emergency department visit (without subsequent hospitalization) or at least 1 hospitalization in the past 4 months at any of the 3 follow-up assessments (4, 8, and 12 months post-baseline)

    baseline to 12-month post-baseline

  • Proportion of Evidence-based Care Components Received Across Follow-up Assessments

    For each individual, this measure is the number of components that were received at any time across the 3 follow-up assessments divided by the number of components they were eligible for at any time across the 3 follow-up assessments, expressed as a proportion. 25 components were evaluated and eligibility for each component varies by individual and follow-up period.

    baseline to 12 months post-baseline

Secondary Outcomes (1)

  • Adaptive Coping Strategies (Social Support Seeking)

    4-, 8-, and 12-months post-baseline

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention is an 8-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM).

Behavioral: CBT Coping Intervention

No-treatment control

NO INTERVENTION

Participants who are assigned to the control group will not receive the intervention.

Interventions

A cognitive behavior therapy group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM).

Intervention

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsBiologically male at birth; Identify as male
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Biologically male at birth
  • Identify as male
  • Self-identify as a Black/African American
  • Report having sex with men in the past 24 months
  • Anticipate being available for the next 12 months to attend study visits
  • Able to interact and communicate in written and spoken English.

You may not qualify if:

  • Unwilling/Unable to provide informed consent
  • Cisgender women
  • Transgender women
  • Transgender men

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

APLA Health

Los Angeles, California, 90016, United States

Location

MeSH Terms

Conditions

Social DiscriminationPatient Acceptance of Health Care

Condition Hierarchy (Ancestors)

Social BehaviorBehaviorTreatment Adherence and ComplianceHealth Behavior

Results Point of Contact

Title
Laura Bogart
Organization
RAND

Study Officials

  • Laura Bogart, PhD

    RAND

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes assessor does not randomize participant until after the baseline assessment
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2020

First Posted

October 14, 2020

Study Start

February 9, 2021

Primary Completion

March 20, 2025

Study Completion

March 20, 2025

Last Updated

November 13, 2025

Results First Posted

November 13, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Following publication of the main study papers, de-identified survey data will be made publicly available to researchers who successfully complete a registration process after requesting to use the data. The data made available will not contain any direct or indirect identifiers. Users must agree to the conditions of use governing access to the public release data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgement of the data resource.

Time Frame
For three years, following publication of the main study papers.
Access Criteria
Users must agree to the conditions of use governing access to the public release data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgement of the data resource. Users must notify the institutional review board of their institution of their intention to use the data and their procedures for data management and security. Users must submit proposals regarding intended use of the data; the RAND study team and the RAND Human Subjects Protections Committee (HSPC) will determine the scientific soundness of the proposal as part of the decision for the researcher to be able to access the dataset.

Locations